The future of drug monitoring in Europe until 2030

Introduction

Patterns of drug use and developments in the drug market in Europe are becoming more complex and dynamic, with major implications for drug monitoring and research. This observation prompted the European Monitoring Centre for Drugs and Drg Addiction (EMCDDA) to conduct a futures exercise 2030 to inform the agency’s strategic reflection on how to improve its activities in the context of both ongoing rapid changes in the information environment and the new information needs likely to emerge over the next decade. A summary of this work is provided here.